14 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
Topical drug formulations ... considerations #pharmacology ... #table #medications ... #treatment #pharmacotherapy ... #dermatology
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
for using anti-infectives ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs ... #pharmacotherapy
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the ... -19 Infection LOPINAVIR ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... #management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
C virus (HCV) infection ... DAAs #Antivirals #table ... #treatment #hcv ... #HepatitisC #Management ... #Pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... -19 Infection ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
in HIV-AIDS Preventing ... ., concomitant medications ... intraocular levels of drug ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... #Treatment #opportunistic ... #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Prophylaxis): Indications ... please refer to Table ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology